Breaking News Instant updates and real-time market news.

V

Visa

$140.06

0.74 (0.53%)

, IBM

IBM

$129.16

-1.36 (-1.04%)

17:45
10/21/18
10/21
17:45
10/21/18
17:45

Visa readies B2B Connect for market

Visa (V) announced new product details surrounding digital identity in preparation for a first quarter 2019 launch of Visa B2B Connect. This distributed ledger-based platform is designed to give financial institutions a simple, fast and secure way to process cross border business-to-business payments globally. B2B Connect's digital identity feature tokenizes an organization's sensitive business information, such as banking details and account numbers, giving them a unique identifier that can be used to facilitate transactions on the platform. Encompassing safety, security and governance all in one solution, B2B Connect's digital identity feature will transform the way information is exchanged in business-to-business cross-border transactions. In preparation for the commercial launch next year, Visa is expanding partnerships to add additional functionality to the B2B Connect platform. As part of the B2B Connect platform, Visa is integrating open source Hyperledger Fabric framework from the Linux Foundation with Visa's core assets. This will help provide an improved process to facilitate financial transactions on a scalable, permissioned network. The work between Visa and IBM (IBM) will enable mutual financial institutional clients and ecosystem to maximize the network. Bottomline Technologies, a leading provider of financial technology that helps make complex business payments simple, smart and secure, is working with Visa to be the first partner to integrate its solution with B2B Connect.

V

Visa

$140.06

0.74 (0.53%)

IBM

IBM

$129.16

-1.36 (-1.04%)

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 28

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

  • 03

    Mar

V Visa
$140.06

0.74 (0.53%)

10/19/18
RHCO
10/19/18
NO CHANGE
Target $88
RHCO
Hold
PayPal price target lowered to $88 from $92 at SunTrust
SunTrust analyst Andrew Jeffrey lowered his price target on Paypal (PYPL) to $88 and kept his Hold rating after its Q3 results, saying that while the company is benefiting from "important secular demand drivers" of eCommerce and Mobile, he remain "guarded" in relation to its Venmo monetization and barriers to entry. The analyst adds that given PayPal's position as a "hybrid" growth company, it lacks a "competitive moat" unlike Visa (V) and MasterCard (MA), arguing that those two offer a superior risk-reward proposition for longer term investors.
10/10/18
PIPR
10/10/18
NO CHANGE
Target $94
PIPR
Neutral
Piper boosts Square target to $94, Global Payments target to $157
Piper Jaffray analyst Jason Deleeuw raised his price target for Neutral-rated Square 9SQ) to $94 from $67 in a research previewing the Q3 earnings reports for his FinTech coverage universe. Key fundamental factors for the sector remain positive, including ongoing secular growth and macro cyclical strength, Deleeuw tells investors in a research note. Also, the group's fundamentals are relatively insulated from the key macro risks of rising input costs and tariff escalation, the analyst adds. As such, he expects in-line to better than consensus Q3 results and outlooks, which he thinks will help stabilize the relative valuation multiples for the group. Deleeuw's top ideas into the quarter include Black Knight (BKI), Global Payments (GPN), First Data (FDC), Visa (V), Euronet (EEFT) and Alliance Data (ADS). In addition to Square, the analyst boosted his price target for Overweight-rated Alliance Data to $319 from $312, Neutral-rated American Express (AXP) to $126 from $113, Overweight-rated Global Payments to $157 from $135, Overweight-rated MasterCard (MA) to $216 from $224, Neutral-rated PayPal (PYPL) to $96 from $81 and Overweight-rated Visa to $191 from $166.
10/08/18
FBCO
10/08/18
NO CHANGE
Target $164
FBCO
Outperform
Visa price target raised to $164 from $150 at Credit Suisse
Credit Suisse analyst Moshe Orenbuch raised his price target for Visa to $164 from $150 ahead of quarterly results. The analyst reiterates an Outperform rating on the shares.
10/03/18
RHCO
10/03/18
NO CHANGE
Target $155
RHCO
Buy
Euronet price target raised to $155 from $130 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on Euronet (EEFT) to $155 and kept his Buy rating, saying he expects the company to post "above trend organic revenue growth" as it rolls out its Dynamic Currency Conversion capability on Visa (V) cards. The analyst further sees Eurnet's Money Transfer business expanding its market share and contributing to near-20% free cash flow growth for the next several years. Jeffrey adds that Euronet shares should see their multiples expand from strong cash flow generation and higher return on invested capital.
IBM IBM
$129.16

-1.36 (-1.04%)

10/18/18
10/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. IBM (IBM) downgraded to Hold from Buy at Argus with analyst James Kelleher saying the company's growth prospects are "fading." 2. Gap (GPS) downgraded to Underweight from Neutral at JPMorgan with analyst Matthew Boss saying the timeframe for sequential same-store-sales improvement at the Gap brand and a return to the "momentum" last seen in the second half of 2017 is now less certain as the brand grapples with operational issues and an "assortment imbalance." 3. Yum! Brands (YUM) downgraded to In Line from Outperform at Evercore ISI with analyst Matt McGinley saying the recent move in shares have placed its valuation closer to the top of its peer franchised peers. 4. EnLink Midstream Partners (ENLK) downgraded to Neutral from Buy at Citi with analyst Mirek Zak citing valuation. 5. Wingstop (WING) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst John Glass citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/18
WEDB
10/18/18
NO CHANGE
Target $165
WEDB
Neutral
IBM price target lowered to $165 from $185 at Wedbush
Wedbush analyst Moshe Katri lowered his price target for IBM to $165 from $185 after the company reported mixed Q3/CY18 results as the "growth" areas at IBM, namely Strategic Imperatives, Cognitive and Cloud are yet to show growth consistency/acceleration while profitability performance also remains unconvincing. The analyst continues to believe that only undertaking the difficult path of aggressively terminating/restructuring underperforming units, hence, sacrificing top-line growth for generating margin/free cash flow improvements will likely generate significant return to shareholders. Katri reiterates a Neutral rating on the shares.
10/18/18
ARGS
10/18/18
DOWNGRADE
ARGS
Hold
IBM downgraded to Hold at Argus on 'fading growth prospects'
As noted earlier, Argus analyst James Kelleher downgraded IBM to Hold after its Q3 revenue miss, saying the company's growth prospects are "fading". The analyst notes that revenues have "flipped back to negative" while margin in key business segments have shrunk. Kelleher adds that even though the stock is trading at a discount, a Hold rating is "appropriate" until the company can show "consistent top-line growth, margin expansion, and earnings acceleration".
10/18/18
ARGS
10/18/18
DOWNGRADE
ARGS
Hold
IBM downgraded to Hold from Buy at Argus

TODAY'S FREE FLY STORIES

SLNO

Soleno Therapeutics

$2.05

-0.04 (-1.91%)

08:07
11/15/18
11/15
08:07
11/15/18
08:07
Hot Stocks
Soleno: DCCR treatment showed statistically significant decreases in body fat »

Soleno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFI

Armstrong Flooring

$14.81

-0.42 (-2.76%)

08:07
11/15/18
11/15
08:07
11/15/18
08:07
Hot Stocks
Armstrong Flooring announces agreement to sell Wood Flooring segment for $100M »

Armstrong Flooring has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASH

Ashland

$80.89

-0.765 (-0.94%)

08:06
11/15/18
11/15
08:06
11/15/18
08:06
Hot Stocks
Ashland to sell composites business, German BDO facility to INEOS for $1.1B »

Ashland announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCRX

Pacira

$47.55

-0.32 (-0.67%)

, CNTX

Centrexion

$0.00

(0.00%)

08:06
11/15/18
11/15
08:06
11/15/18
08:06
Conference/Events
FDA Anesthetic & Analgesic Drug Products Advisory Committee to hold meeting »

The Committee discusses…

PCRX

Pacira

$47.55

-0.32 (-0.67%)

CNTX

Centrexion

$0.00

(0.00%)

FLXN

Flexion

$16.21

-0.19 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 15

    Nov

CVS

CVS Health

$79.92

-0.9 (-1.11%)

08:04
11/15/18
11/15
08:04
11/15/18
08:04
Hot Stocks
CVS Health announces new collaboration with Philadelphia Job Corps »

CVS Health has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSMT

PriceSmart

$66.24

-0.53 (-0.79%)

08:04
11/15/18
11/15
08:04
11/15/18
08:04
Hot Stocks
PriceSmart to build a new warehouse club in Panama »

PriceSmart signed a lease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMRK

Landmark Infrastructure

$13.46

0.32 (2.44%)

08:03
11/15/18
11/15
08:03
11/15/18
08:03
Hot Stocks
Landmark Infrastructure board approves $20M unit purchase program »

Landmark Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$53.11

-1.73 (-3.15%)

08:03
11/15/18
11/15
08:03
11/15/18
08:03
Hot Stocks
Seattle Genetics receives Breakthrough Therapy Designation for ADCETRIS »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

CUB

Cubic

$63.93

-1.4 (-2.14%)

08:03
11/15/18
11/15
08:03
11/15/18
08:03
Earnings
Cubic sees FY19 revenue $1.37B-$1.45B, consensus $1.3B »

Sees FY19 adjusted EBItDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CUB

Cubic

$63.93

-1.4 (-2.14%)

08:02
11/15/18
11/15
08:02
11/15/18
08:02
Earnings
Cubic reports Q4 EPS 80c vs. 35c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BIG

Big Lots

$42.56

-1.46 (-3.32%)

08:01
11/15/18
11/15
08:01
11/15/18
08:01
Options
Big Lots put buyer realizes 16% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$64.33

5.73 (9.78%)

08:00
11/15/18
11/15
08:00
11/15/18
08:00
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

07:59
11/15/18
11/15
07:59
11/15/18
07:59
Upgrade
Mylan rating change  »

Mylan upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$65.09

-2.22 (-3.30%)

07:59
11/15/18
11/15
07:59
11/15/18
07:59
Recommendations
Alnylam analyst commentary  »

Alnylam management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

CUBE

CubeSmart

$29.75

0.46 (1.57%)

07:57
11/15/18
11/15
07:57
11/15/18
07:57
Upgrade
CubeSmart rating change  »

CubeSmart upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$64.33

5.73 (9.78%)

07:56
11/15/18
11/15
07:56
11/15/18
07:56
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KREF

KKR Real Estate Finance

$20.56

-0.06 (-0.29%)

07:55
11/15/18
11/15
07:55
11/15/18
07:55
Syndicate
KKR Real Estate Finance 4.5M share Spot Secondary priced at $20.15 »

Morgan Stanley, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

LBTYA

Liberty Global

$24.27

0.6 (2.53%)

07:53
11/15/18
11/15
07:53
11/15/18
07:53
Periodicals
Liberty Global CFO says it is not desperate to divest UPC unit, Reuters reports »

Liberty Global is not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ALB

Albemarle

$99.95

0.72 (0.73%)

07:53
11/15/18
11/15
07:53
11/15/18
07:53
Initiation
Albemarle initiated  »

Albemarle initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

, ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

07:52
11/15/18
11/15
07:52
11/15/18
07:52
Initiation
ProQR Therapeutics, Spark Therapeutics initiated  »

ProQR Therapeutics…

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:50
11/15/18
11/15
07:50
11/15/18
07:50
General news
U.S. retail sales preview: »

U.S. retail sales…

O

Realty Income

$63.17

0.32 (0.51%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRC

Spirit Realty

$8.04

-0.065 (-0.80%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Spirit Realty rating change  »

Spirit Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$17.34

-0.155 (-0.89%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Eagle Point Credit rating change  »

Eagle Point Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFE

Safety, Income and Growth

$18.97

(0.00%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Safety, Income and Growth rating change  »

Safety, Income and Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.